Our dedicated Pharmacokinetics group works closely with other operational departments to provide pharmacokinetic data for animal and human radiolabelled studies, human clinical trials, and veterinary clinical studies in a timely fashion. Utilizing industry-standard WinNonlin® software, we can provide the following services:
- Input into study design, including preclinical-to-clinical considerations (allometric scaling) utilizing information from preclinical toxicokinetic studies
- Non-compartmental pharmacokinetics
- Compartmental pharmacokinetics/simulations
- Ascending dose (assessment of dose proportionality)
- Repeat dose (assessment of multiple dose linearity)
- Bioavailability and bioequivalence
- Drug interaction studies
- Special populations
- Pharmacodynamic and PK/PD modeling
- Deconvolution
Our pharmacokinetic consultancy service provides advice and support for all aspects of clinical pharmacokinetics and is offered as part of a complete development program, as a full-service single-study package, or as a stand-alone service. Upon request, pharmacokinetic parameter estimation output and reports may include a comprehensive text interpretation of the data.
For help with more of your research and drug development needs, see our Toxicokinetics and Clinical Pharmacokinetics capabilities.
|
Pharmacokinetics, pk studies, pk, pharmacokinetic data, pharmacokinetic studies, GLP, preclinical studies, allometric scaling, Non-compartmental pharmacokinetics, Compartmental pharmacokinetics, Ascending dose studies, dose proportionality assessment, multiple dose linearity, Bioavailability, bioequivalence, Drug interaction studies, Pharmacodynamic, Deconvolution
Pharmacokinetics | Preclinical Services | Charles River
Charles River's Pharmacokinetics group designs and conducts GLP-compliant pharmacokinetic studies to examine multiple parameters, such as dose proportionality, bioavailability, and food effects, in both single and multiple dose studies.